Cargando…
Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
Ebolaviruses pose significant public health problems due to their high lethality, unpredictable emergence, and localization to the poorest areas of the world. In addition to implementation of standard public health control procedures, a number of experimental human vaccines are being explored as a f...
Autores principales: | Marzi, Andrea, Murphy, Aisling A., Feldmann, Friederike, Parkins, Christopher J., Haddock, Elaine, Hanley, Patrick W., Emery, Matthew J., Engelmann, Flora, Messaoudi, Ilhem, Feldmann, Heinz, Jarvis, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753684/ https://www.ncbi.nlm.nih.gov/pubmed/26876974 http://dx.doi.org/10.1038/srep21674 |
Ejemplares similares
-
A Replicating Cytomegalovirus-Based Vaccine Encoding a Single Ebola Virus Nucleoprotein CTL Epitope Confers Protection against Ebola Virus
por: Tsuda, Yoshimi, et al.
Publicado: (2011) -
A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge
por: Domi, Arban, et al.
Publicado: (2018) -
Effective Chemical Inactivation of Ebola Virus
por: Haddock, Elaine, et al.
Publicado: (2016) -
Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
por: Blaney, Joseph E., et al.
Publicado: (2013) -
Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
por: Bhatia, Bharti, et al.
Publicado: (2021)